Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 688-489-2 | CAS number: 1024700-50-2
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
Not much information is available.
The substance is a salt consisting of an ion pair of C10-13-sec alkylbenzene sulphonate (ABS) as anion and a methacrylamide cation. Due to the ionic nature of the salt bioavailability via oral route is expected, whereas dermal absorption is likely to be limited.
Comparing results from 14-day range finder and full OECD 422 study on the structural homologue MAPTA-ABS salt, indicate that following high dose administration toxicity symptoms appear within two days, and also clear again within two days after stopping dosing. There is no increase of toxicity symptoms with prolongation of dosing. This indicates the substance does not accumulate, and excretion is reasonably rapid.Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
